MedTrace Logo

Hemostasis Using Surgicel in Pediatric Tonsillectomy

NCT03984851 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 203

Last updated 2019-06-13

No results posted yet for this study

Summary

Tonsillectomy is one of the commonest procedures performed in otolaryngology and one of its major complications is post-tonsillectomy bleeding.

The goal of this study was to assess the effectiveness of Surgicel without bipolar cautery in achieving primary hemostasis in tonsillectomy. The patient that were enrolled in this retrospective study were patients who underwent tonsillectomy and achieved hemostasis either by Surgicel (group A) or bipolar cautery (group B). Our results showed that there was no statistical significant difference between the two techniques in terms of post-operative bleeding events.

Conditions

  • Tonsil; Injury
  • Surgical Blood Loss

Sponsors & Collaborators

  • Dr. Abdul Mohsen Ibrahim Al-Turki Clinic

    lead OTHER

Eligibility

Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2018-08-01
Completion
2019-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03984851 on ClinicalTrials.gov